
|Videos|January 23, 2014
Recent Events Raise Awareness of BRCA Testing
Author(s)Sharon Tollin, PhD, ARNP-BC, OCN®
Sharon Tollin, PhD, ARNP-BC, OCN®, H. Lee Moffitt Cancer Center & Research Institute, discusses changes to the awareness of BRCA testing and breast cancer risk.
Advertisement
Clinical Pearls
Sharon Tollin, PhD, ARNP-BC, OCN®, H. Lee Moffitt Cancer Center & Research Institute, discusses heightened awareness of BRCA testing and breast cancer risk.
- Awareness to BRCA testing has increased in the past months
- The Myriad Genetics court case ruling represents a change to science, research, and affordability
- Angelina Jolie’s double mastectomy announcement has had an enormous ripple effect with patients regarding their risk
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
Breast Cancer Test Using Proteomic Profiling and AI Demonstrates High Performance
5










































